These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32899160)

  • 1. Proteostasis and Proteotoxicity in the Network Medicine Era.
    Lualdi M; Alberio T; Fasano M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways of cellular proteostasis in aging and disease.
    Klaips CL; Jayaraj GG; Hartl FU
    J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
    Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
    Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of Proteostasis Capacity and Protein Aggregation: Implications for Cellular Function and Disease.
    Hipp MS; Hartl FU
    J Mol Biol; 2024 Jul; 436(14):168615. PubMed ID: 38759929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the Role of Normal Aging Processes in the Onset and Pathogenesis of Diseases Associated with the Abnormal Accumulation of Protein Aggregates.
    Ilyinsky NS; Nesterov SV; Shestoperova EI; Fonin AV; Uversky VN; Gordeliy VI
    Biochemistry (Mosc); 2021 Mar; 86(3):275-289. PubMed ID: 33838629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.
    Elmatboly AM; Sherif AM; Deeb DA; Benmelouka A; Bin-Jumah MN; Aleya L; Abdel-Daim MM
    Environ Sci Pollut Res Int; 2020 Apr; 27(11):11461-11483. PubMed ID: 32072427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Assemblies at the Crossroads of Aging, Proteostasis, and Neurodegeneration.
    Roitenberg N; Cohen E
    Trends Cell Biol; 2019 Dec; 29(12):954-963. PubMed ID: 31669295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluc-EGFP reporter mice reveal differential alterations of neuronal proteostasis in aging and disease.
    Blumenstock S; Schulz-Trieglaff EK; Voelkl K; Bolender AL; Lapios P; Lindner J; Hipp MS; Hartl FU; Klein R; Dudanova I
    EMBO J; 2021 Oct; 40(19):e107260. PubMed ID: 34410010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular protein homeostasis in neurodegenerative diseases.
    Wilson MR; Satapathy S; Vendruscolo M
    Nat Rev Neurol; 2023 Apr; 19(4):235-245. PubMed ID: 36828943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Modules of the Proteostasis Network.
    Jayaraj GG; Hipp MS; Hartl FU
    Cold Spring Harb Perspect Biol; 2020 Jan; 12(1):. PubMed ID: 30833457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
    Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
    Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-Antitrypsin Deficiency: A Disorder of Proteostasis-Mediated Protein Folding and Trafficking Pathways.
    Karatas E; Bouchecareilh M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular chaperones and neuronal proteostasis.
    Smith HL; Li W; Cheetham ME
    Semin Cell Dev Biol; 2015 Apr; 40():142-52. PubMed ID: 25770416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Walking the tightrope: proteostasis and neurodegenerative disease.
    Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
    J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoplasmic reticulum proteostasis impairment in aging.
    Martínez G; Duran-Aniotz C; Cabral-Miranda F; Vivar JP; Hetz C
    Aging Cell; 2017 Aug; 16(4):615-623. PubMed ID: 28436203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.